Prolonged survival of a patient with pelvic recurrence of ovarian malignant mixed mullerian tumor after chemoradiotherapy

Introduction : Malignant Mixed Mullerian Tumor (MMMT) is a very rare tumor, accounting for less than 1 % of all ovarian cancers. Case Presentation : We present a 64-year-old woman with stage III MMMT of ovary that was treated with platinum-based chemotherapy after optimal cytoreductive surgery. Afte...

Full description

Saved in:
Bibliographic Details
Published inIranian red crescent medical journal Vol. 16; no. 9; pp. 1 - 4
Main Authors Mufrad, Malihe Hasanzade, Sistani, Nuriah Shurayfi, Marvast, Majid Nabizadah, Sadiqi, Mahbubi, Shandiz, Fatimah Homaei, Kadkhodayan, Sima, Roodsari, Zuhari Yusuf
Format Journal Article
LanguageEnglish
Published Dubai, United Arab Emirates Iranian Hospital 01.09.2014
Kowsar
Subjects
Cancer
Case Report
Chemotherapy
Ovaries
Treatment
السرطان
العلاج الكيميائي
Ovary
Chemotherapy
Chemoradiotherapy
Cytoreductive Surgery
Mixed Tumor, Mullerian
Online AccessGet full text

Cover

More Information
Summary:Introduction : Malignant Mixed Mullerian Tumor (MMMT) is a very rare tumor, accounting for less than 1 % of all ovarian cancers. Case Presentation : We present a 64-year-old woman with stage III MMMT of ovary that was treated with platinum-based chemotherapy after optimal cytoreductive surgery. After 25 months of being disease free, she had a pelvic recurrence and a good response to chemoradiotherapy. Conclusions : Optimal cytoreductive surgery and chemotherapy may be the best treatment in MMMT but more discussion and experiences are needed regarding the effectiveness of radiotherapy.
ISSN:2074-1804
2074-1812
DOI:10.5812/ircmj.14919